| Saham Orang Dalam | 347,910 shares |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
N/A
Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
N/A
Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Biocept Inc transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di BIOC / Biocept Inc. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di BIOC / Biocept Inc. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 | 2022-03-31 | 4 | Taylor Darrell | BIOC | Stock Option (right to buy) | D | 2.32 | 15,450 | 15,450 | |||||
| 2022-04-04 | 2022-03-31 | 4 | Marchand Philippe | BIOC | Stock Option (right to buy) | D | 2.32 | 150,000 | 150,000 | |||||
| 2022-03-16 | 2022-02-28 | 4 | Taylor Darrell | BIOC | Stock Option (right to buy) | D | 2.39 | 134,550 | 134,550 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Riccitelli Samuel D | BIOC | Stock Option (right to buy) | D | 2.39 | 250,000 | 250,000 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Morales Antonino | BIOC | Stock Option (right to buy) | D | 2.39 | 150,000 | 150,000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | HALE DAVID F | BIOC | Common Stock | D | 4.0664 | -71 | -0 | 796 | ||||
| 2021-12-10 | 2021-12-09 | 4 | HALE DAVID F By trust | BIOC | Common Stock | I | 4.0717 | -11 | -0 | 101 | ||||
| 2021-12-10 | 2021-12-09 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | 4.0602 | -363 | -1 | 3,114 | ||||
| 2021-09-02 | 2021-09-02 | 4 | Nall Michael W. | BIOC | Performance-Based Employee Stock Option (right to buy) | D | 3.76 | 80,000 | 80,000 | |||||
| 2021-09-02 | 2021-09-02 | 4 | Nall Michael W. | BIOC | Employee Stock Option (right to buy) | D | 3.76 | 100,000 | 100,000 | |||||
| 2021-09-02 | 2021-08-31 | 4 | DUGAN MICHAEL C | BIOC | Employee Stock Option (right to buy) | D | 3.62 | 150,000 | 150,000 | |||||
| 2021-09-02 | 2021-08-31 | 4 | TERRY MICHAEL J | BIOC | Employee Stock Option (right to buy) | D | 3.62 | 35,000 | 35,000 | |||||
| 2021-09-02 | 2021-08-31 | 4 | Kennedy Timothy | BIOC | Employee Stock Option (right to buy) | D | 3.62 | 100,000 | 100,000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 3.77 | 10,000 | 10,000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 3.77 | 10,000 | 10,000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 3.77 | 10,000 | 10,000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 3.77 | 10,000 | 10,000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Riccitelli Samuel D | BIOC | Employee Stock Option (right to buy) | D | 3.77 | 10,000 | 10,000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 3.77 | 10,000 | 10,000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Rubinstein Linda M | BIOC | Employee Stock Option (right to buy) | D | 3.77 | 10,000 | 10,000 | |||||
| 2021-07-20 | 2021-07-16 | 4 | Morales Antonino | BIOC | Employee Stock Option (right to buy) | D | 3.77 | 10,000 | 10,000 | |||||
| 2021-07-20 | 3 | Rubinstein Linda M | BIOC | No securities are beneficially owned | D | 0 | ||||||||
| 2021-07-20 | 3 | Morales Antonino | BIOC | No securities are beneficially owned | D | 0 | ||||||||
| 2020-10-22 | 2020-10-20 | 4 | Riccitelli Samuel D | BIOC | Employee Stock Option (right to buy) | D | 4.63 | 10,000 | 10,000 | |||||
| 2020-10-05 | 2020-10-01 | 4 | Kennedy Timothy | BIOC | Employee Stock Option (right to buy) | D | 4.50 | 138,000 | 138,000 | |||||
| 2020-10-05 | 2020-10-01 | 4 | TERRY MICHAEL J | BIOC | Employee Stock Option (right to buy) | D | 4.50 | 48,300 | 48,300 | |||||
| 2020-10-05 | 2020-10-01 | 4 | DUGAN MICHAEL C | BIOC | Employee Stock Option (right to buy) | D | 4.50 | 69,000 | 69,000 | |||||
| 2020-10-05 | 2020-10-01 | 4 | Nall Michael W. | BIOC | Employee Stock Option (right to buy) | D | 4.50 | 241,500 | 241,500 | |||||
| 2020-09-01 | 2020-08-31 | 4 | DUGAN MICHAEL C | BIOC | Employee Stock Option (right to buy) | D | 0.66 | 54,900 | 54,900 | |||||
| 2020-08-27 | 3 | DUGAN MICHAEL C | BIOC | Common Stock | D | 5,700 | ||||||||
| 2020-06-12 | 2020-06-12 | 4 | HALE DAVID F | BIOC | Common Stock | D | 0.5550 | -556 | -0 | 867 | ||||
| 2020-06-12 | 2020-06-12 | 4 | HALE DAVID F By trust | BIOC | Common Stock | I | 0.5545 | -445 | -0 | 112 | ||||
| 2020-06-12 | 2020-06-12 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | 0.5578 | -159 | -0 | 3,477 | ||||
| 2020-06-09 | 2020-06-05 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 0.48 | 500 | 500 | |||||
| 2020-06-09 | 2020-06-05 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 0.48 | 500 | 500 | |||||
| 2020-06-09 | 2020-06-05 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 0.48 | 500 | 500 | |||||
| 2020-06-09 | 2020-06-05 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 0.48 | 500 | 500 | |||||
| 2020-06-09 | 2020-06-05 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 0.48 | 500 | 500 | |||||
| 2020-06-09 | 2020-06-05 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 0.48 | 500 | 500 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 1.02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 30,000 | 30,000 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 1.02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 30,000 | 30,000 | |||||
| 2019-06-19 | 2019-06-17 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 1.02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 30,000 | 30,000 | |||||
| 2019-06-19 | 2019-06-17 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 1.02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 30,000 | 30,000 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Nall Michael W. | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 675,000 | 675,000 | |||||
| 2019-06-19 | 2019-04-30 | 4 | TERRY MICHAEL J | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 90,000 | 90,000 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Hendrick Edwin | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 160,000 | 160,000 | |||||
| 2019-06-19 | 2019-04-30 | 4 | ARNOLD LYLE J | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 175,000 | 175,000 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 1.02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 30,000 | 30,000 | |||||
| 2019-06-19 | 2019-06-17 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 1.02 | 500 | 500 | |||||
| 2019-06-19 | 2019-04-30 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 30,000 | 30,000 | |||||
| 2019-06-19 | 2019-04-30 | 4 | Kennedy Timothy | BIOC | Employee Stock Option (right to buy) | D | 0.91 | 400,000 | 400,000 | |||||
| 2018-10-02 | 2018-09-28 | 4 | Hendrick Edwin | BIOC | Employee Stock Option (right to buy) | D | 2.75 | 45,000 | 45,000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 0.20 | 15,000 | 15,000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 0.20 | 15,000 | 15,000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 0.20 | 15,000 | 15,000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 0.20 | 15,000 | 15,000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 0.20 | 15,000 | 15,000 | |||||
| 2018-07-02 | 2018-06-29 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 0.20 | 15,000 | 15,000 | |||||
| 2018-06-06 | 2018-01-30 | 4 | Gerhardt Bruce | BIOC | Warrant to Purchase Common Stock | D | 0.50 | 25,000 | 25,000 | |||||
| 2018-06-06 | 2018-01-30 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 25,000 | 98,303 | ||||||
| 2017-08-17 | 3 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 6,295,334 | ||||||||
| 2017-08-17 | 3 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 6,295,334 | ||||||||
| 2017-08-17 | 3 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 6,295,334 | ||||||||
| 2017-08-17 | 3 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 6,295,334 | ||||||||
| 2017-08-17 | 3 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 6,295,334 | ||||||||
| 2017-06-02 | 2017-05-31 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 15,000 | 15,000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 15,000 | 15,000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Neff Edward A. | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 15,000 | 15,000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 15,000 | 15,000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 15,000 | 15,000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Nall Michael W. | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 300,000 | 300,000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Nall Michael W. | BIOC | Common Stock | D | 50,000 | 75,000 | ||||||
| 2017-06-02 | 2017-05-31 | 4 | Kennedy Timothy | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 50,000 | 50,000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Kennedy Timothy | BIOC | Common Stock | D | 25,000 | 86,363 | ||||||
| 2017-06-02 | 2017-05-31 | 4 | ARNOLD LYLE J | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 75,000 | 75,000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | ARNOLD LYLE J | BIOC | Common Stock | D | 25,000 | 90,238 | ||||||
| 2017-06-02 | 2017-05-31 | 4 | Singh Veena | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 50,000 | 50,000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Singh Veena | BIOC | Common Stock | D | 25,000 | 51,666 | ||||||
| 2017-06-02 | 2017-05-31 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 15,000 | 15,000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 1.50 | 15,000 | 15,000 | |||||
| 2017-04-03 | 2017-03-31 | 4 | Neff Edward A. | BIOC | Employee Stock Option (right to buy) | D | 2.13 | 4,166 | 4,166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | Wilson Margaret Faye | BIOC | Employee Stock Option (right to buy) | D | 2.13 | 4,166 | 4,166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | Chandler Marsha Alpert | BIOC | Employee Stock Option (right to buy) | D | 2.13 | 4,166 | 4,166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | HALE DAVID F | BIOC | Employee Stock Option (right to buy) | D | 2.13 | 4,166 | 4,166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | ROYSTON IVOR | BIOC | Employee Stock Option (right to buy) | D | 2.13 | 4,166 | 4,166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | Gerhardt Bruce | BIOC | Employee Stock Option (right to buy) | D | 2.13 | 4,166 | 4,166 | |||||
| 2017-04-03 | 2017-03-31 | 4 | HUEBNER BRUCE A | BIOC | Employee Stock Option (right to buy) | D | 2.13 | 4,166 | 4,166 | |||||
| 2017-03-29 | 2015-03-16 | 4 | ROYSTON IVOR | BIOC | Common Stock | D | 8.7600 | 5,667 | 50 | 17,294 | ||||
| 2017-03-22 | 2017-03-21 | 4 | Kennedy Timothy | BIOC | Employee stock option (right to buy) | D | 1.95 | 16,383 | 16,383 | |||||
| 2017-03-22 | 2017-03-21 | 4 | Nall Michael W. | BIOC | Employee stock option (right to buy) | D | 4.02 | 10,000 | 10,000 | |||||
| 2017-03-22 | 2017-03-21 | 4 | Nall Michael W. | BIOC | Employee stock option (right to buy) | D | 6.03 | 6,333 | 6,333 | |||||
| 2017-02-28 | 2017-02-28 | 4 | TERRY MICHAEL J | BIOC | Employee Stock Option (right to buy) | D | 2.05 | 50,000 | 50,000 | |||||
| 2017-02-16 | 3 | TERRY MICHAEL J | BIOC | Common Stock | D | 5,800 | ||||||||
| 2017-02-16 | 3 | TERRY MICHAEL J | BIOC | Common Stock | D | 5,800 | ||||||||
| 2017-01-26 | 2017-01-19 | 4 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 1.1000 | -254,893 | -280 | 0 | ||||
| 2017-01-26 | 2017-01-18 | 4 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 1.1000 | -549,708 | -605 | 254,893 | ||||
| 2017-01-26 | 2017-01-17 | 4 | Ally Bridge LB Healthcare Master Fund Ltd | BIOC | Common Stock | D | 1.1000 | -876,399 | -964 | 804,601 | ||||
| 2016-10-24 | 3 | Li Bin | BIOC | Common Stock | D | 3,362,000 | ||||||||
| 2016-10-24 | 3 | Li Bin | BIOC | Common Stock | D | 3,362,000 | ||||||||
| 2016-10-24 | 3 | Li Bin | BIOC | Common Stock | D | 3,362,000 | ||||||||
| 2016-10-24 | 3 | Li Bin | BIOC | Common Stock | D | 3,362,000 | ||||||||
| 2016-10-24 | 3 | Li Bin | BIOC | Common Stock | D | 3,362,000 | ||||||||
| 2016-10-21 | 3/A | HALE DAVID F By Trust | BIOC | Common Stock | I | 10,204 | ||||||||
| 2016-10-21 | 2016-10-19 | 4 | HALE DAVID F By LLC | BIOC | Warrant to Purchase Common Stock | I | 1.10 | 90,909 | 90,909 | |||||
| 2016-10-21 | 2016-10-19 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | 1.1000 | 90,909 | 100 | 109,099 | ||||
| 2016-10-21 | 2016-06-16 | 4 | HALE DAVID F By trust | BIOC | Common Stock | I | 13,334 | 16,736 | ||||||
| 2016-10-21 | 2016-06-16 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | -13,334 | 18,190 | ||||||
| 2016-10-21 | 2016-10-19 | 4 | HUEBNER BRUCE A | BIOC | Warrant to Purchase Common Stock | D | 1.10 | 20,000 | 20,000 | |||||
| 2016-10-21 | 2016-10-19 | 4 | HUEBNER BRUCE A | BIOC | Common Stock | D | 1.1000 | 20,000 | 22 | 24,000 | ||||
| 2016-10-21 | 2016-10-19 | 4 | ARNOLD LYLE J | BIOC | Warrant to Purchase Common Stock | D | 1.10 | 45,000 | 45,000 | |||||
| 2016-10-21 | 2016-10-19 | 4 | ARNOLD LYLE J | BIOC | Common Stock | D | 1.1000 | 45,000 | 50 | 65,238 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Wilson Margaret Faye | BIOC | Warrant to Purchase Common Stock | D | 1.10 | 13,636 | 13,636 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Wilson Margaret Faye | BIOC | Common Stock | D | 1.1000 | 13,636 | 15 | 25,067 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Gerhardt Bruce | BIOC | Warrant to Purchase Common Stock | D | 1.10 | 50,000 | 50,000 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 1.1000 | 50,000 | 55 | 73,304 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Chandler Marsha Alpert | BIOC | Warrant to Purchase Common Stock | D | 1.10 | 4,545 | 4,545 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Chandler Marsha Alpert | BIOC | Common Stock | D | 1.1000 | 4,545 | 5 | 5,212 | ||||
| 2016-10-21 | 2014-03-04 | 4 | Chandler Marsha Alpert By trust | BIOC | Common Stock | I | 1,693 | 1,693 | ||||||
| 2016-10-21 | 2014-03-04 | 4 | Chandler Marsha Alpert | BIOC | Common Stock | D | -1,693 | 667 | ||||||
| 2016-10-21 | 2016-10-19 | 4 | Nall Michael W. | BIOC | Warrant to Purchase Common Stock | D | 1.10 | 36,363 | 36,363 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Nall Michael W. By trust | BIOC | Common Stock | I | 1.1000 | 36,363 | 40 | 49,575 | ||||
| 2016-10-21 | 2016-03-09 | 4 | Nall Michael W. By trust | BIOC | Common Stock | I | 4,450 | 13,212 | ||||||
| 2016-10-21 | 2016-03-09 | 4 | Nall Michael W. | BIOC | Common Stock | D | -4,450 | 25,000 | ||||||
| 2016-10-21 | 2015-09-01 | 4 | Nall Michael W. By trust | BIOC | Common Stock | I | 4,762 | 8,762 | ||||||
| 2016-10-21 | 2015-09-01 | 4 | Nall Michael W. | BIOC | Common Stock | D | -4,762 | 29,450 | ||||||
| 2016-10-21 | 2015-04-30 | 4 | Nall Michael W. By trust | BIOC | Common Stock | I | 4,000 | 4,000 | ||||||
| 2016-10-21 | 2015-04-30 | 4 | Nall Michael W. | BIOC | Common Stock | D | -4,000 | 34,212 | ||||||
| 2016-10-21 | 2016-10-19 | 4 | Neff Edward A. | BIOC | Warrant to Purchase Common Stock | D | 1.10 | 227,272 | 227,272 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Neff Edward A. By corporation | BIOC | Common Stock | I | 1.1000 | 227,272 | 250 | 289,735 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Reiss Claire By trusts | BIOC | Warrant to Purchase Common Stock | I | 1.10 | 227,272 | 227,272 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Reiss Claire By trusts | BIOC | Common Stock | I | 1.1000 | 227,272 | 250 | 1,046,613 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Singh Veena | BIOC | Warrant to Purchase Common Stock | D | 1.10 | 10,000 | 10,000 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Singh Veena | BIOC | Common Stock | D | 1.1000 | 10,000 | 11 | 26,666 | ||||
| 2016-10-21 | 2016-10-19 | 4 | Kennedy Timothy | BIOC | Warrant to Purchase Common Stock | D | 1.10 | 36,363 | 36,363 | |||||
| 2016-10-21 | 2016-10-19 | 4 | Kennedy Timothy | BIOC | Common Stock | D | 1.1000 | 36,363 | 40 | 61,363 | ||||
| 2016-08-01 | 2016-07-29 | 4 | Kennedy Timothy | BIOC | Employee Stock Option (right to buy) | D | 0.65 | 200,000 | 200,000 | |||||
| 2016-08-01 | 2016-07-29 | 4 | Kennedy Timothy | BIOC | Common Stock | D | 75,000 | 75,000 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | ARNOLD LYLE J | BIOC | Common Stock | D | 50,000 | 60,714 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Nall Michael W. | BIOC | Common Stock | D | 75,000 | 114,634 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Singh Veena | BIOC | Common Stock | D | 50,000 | 50,000 | ||||||
| 2016-05-05 | 3/A | Reiss Claire By corporation | BIOC | Common Stock | I | 14,012 | ||||||||
| 2016-05-05 | 2016-05-04 | 4 | HALE DAVID F | BIOC | Warrant to Purchase Common Stock | D | 1.30 | 35,000 | 35,000 | |||||
| 2016-05-05 | 2016-05-04 | 4 | HALE DAVID F | BIOC | Common Stock | D | 1.0000 | 50,000 | 50 | 138,356 | ||||
| 2016-05-05 | 2016-05-04 | 4 | Gerhardt Bruce | BIOC | Warrant to Purchase Common Stock | D | 1.30 | 17,500 | 17,500 | |||||
| 2016-05-05 | 2016-05-04 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 1.0000 | 25,000 | 25 | 58,985 | ||||
| 2016-05-05 | 2016-05-04 | 4 | Neff Edward A. | BIOC | Warrant to Purchase Common Stock | D | 1.30 | 70,000 | 70,000 | |||||
| 2016-05-05 | 2016-05-04 | 4 | Neff Edward A. | BIOC | Common Stock | D | 1.0000 | 100,000 | 100 | 112,913 | ||||
| 2016-05-05 | 2016-05-04 | 4 | Reiss Claire By trusts | BIOC | Warrant to Purchase Common Stock | I | 1.30 | 429,991 | 429,991 | |||||
| 2016-05-05 | 2016-05-04 | 4 | Reiss Claire By trusts | BIOC | Common Stock | I | 1.0000 | 614,273 | 614 | 2,458,016 | ||||
| 2016-03-01 | 2016-02-29 | 4 | ARNOLD LYLE J | BIOC | Employee Stock Option (right to buy) | D | 1.34 | 25,000 | 25,000 | |||||
| 2016-03-01 | 2016-02-29 | 4 | Nall Michael W. | BIOC | Employee stock option (right to buy) | D | 1.34 | 50,000 | 50,000 | |||||
| 2016-03-01 | 2016-02-29 | 4 | Nall Michael W. | BIOC | Common Stock | D | 13,348 | 39,634 | ||||||
| 2016-03-01 | 2016-02-29 | 4 | Trivedi Raaj | BIOC | Employee Stock Option (right to buy) | D | 1.34 | 17,500 | 17,500 | |||||
| 2016-03-01 | 2016-02-29 | 4 | Singh Veena | BIOC | Employee Stock Option (right to buy) | D | 1.34 | 50,000 | 50,000 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Wilson Margaret Faye | BIOC | Stock Option (right to buy) | D | 1.38 | 12,500 | 12,500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Neff Edward A. | BIOC | Stock Option (right to buy) | D | 1.38 | 12,500 | 12,500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Gerhardt Bruce | BIOC | Stock Option (right to buy) | D | 1.38 | 12,500 | 12,500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | Chandler Marsha Alpert | BIOC | Stock Option (right to buy) | D | 1.38 | 12,500 | 12,500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | ROYSTON IVOR | BIOC | Stock Option (right to buy) | D | 1.38 | 12,500 | 12,500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | HALE DAVID F | BIOC | Stock Option (right to buy) | D | 1.38 | 12,500 | 12,500 | |||||
| 2016-01-04 | 2015-12-31 | 4 | HUEBNER BRUCE A | BIOC | Stock Option (right to buy) | D | 1.38 | 12,500 | 12,500 | |||||
| 2015-11-10 | 2015-11-09 | 4 | ROYSTON IVOR | BIOC | Restricted Stock Units | D | -9,285 | 0 | ||||||
| 2015-11-10 | 2015-11-09 | 4 | ROYSTON IVOR | BIOC | Common Stock | D | 9,285 | 34,878 | ||||||
| 2015-11-10 | 2015-11-09 | 4 | HALE DAVID F | BIOC | Restricted Stock Units | D | -53,662 | 0 | ||||||
| 2015-11-10 | 2015-11-09 | 4 | HALE DAVID F | BIOC | Restricted Stock Units | D | -10,204 | 0 | ||||||
| 2015-11-10 | 2015-11-09 | 4 | HALE DAVID F | BIOC | Common Stock | D | 53,662 | 88,356 | ||||||
| 2015-11-10 | 2015-11-09 | 4 | HALE DAVID F | BIOC | Common Stock | D | 10,204 | 34,694 | ||||||
| 2015-09-02 | 2015-08-31 | 4 | Singh Veena | BIOC | Employee Stock Option (right to buy) | D | 2.01 | 175,000 | 175,000 | |||||
| 2015-09-02 | 2015-08-31 | 4 | Trivedi Raaj | BIOC | Employee Stock Option (right to buy) | D | 2.01 | 47,000 | 47,000 | |||||
| 2015-09-02 | 2015-08-31 | 4 | Nall Michael W. | BIOC | Employee Stock Option (right to buy) | D | 2.01 | 150,000 | 150,000 | |||||
| 2015-09-02 | 2015-08-31 | 4 | FOLETTA MARK G | BIOC | Employee Stock Option (right to buy) | D | 2.01 | 50,000 | 50,000 | |||||
| 2015-09-02 | 2015-08-31 | 4 | ARNOLD LYLE J | BIOC | Employee Stock Option (right to buy) | D | 2.01 | 175,000 | 175,000 | |||||
| 2015-08-25 | 2015-08-24 | 4 | Nall Michael W. | BIOC | Restricted Stock Units | D | -14,286 | 0 | ||||||
| 2015-08-25 | 2015-08-24 | 4 | Nall Michael W. | BIOC | Common Stock | D | 14,286 | 26,286 | ||||||
| 2015-08-25 | 2015-08-24 | 4 | ARNOLD LYLE J | BIOC | Restricted Stock Units | D | -10,714 | 0 | ||||||
| 2015-08-25 | 2015-08-24 | 4 | ARNOLD LYLE J | BIOC | Common Stock | D | 10,714 | 10,714 | ||||||
| 2015-08-25 | 2015-08-24 | 4 | HALE DAVID F | BIOC | Restricted Stock Units | D | -14,286 | 0 | ||||||
| 2015-08-25 | 2015-08-24 | 4 | HALE DAVID F | BIOC | Common Stock | D | 14,286 | 24,490 | ||||||
| 2015-08-20 | 3 | FOLETTA MARK G | BIOC | No securities are beneficially owned | D | 0 | ||||||||
| 2015-07-08 | 2015-05-24 | 4 | Gerhardt Bruce | BIOC | Restricted Stock Units | D | -8,735 | 0 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 8,735 | 33,985 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | Neff Edward A. | BIOC | Restricted Stock Units | D | -8,735 | 0 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | Neff Edward A. | BIOC | Common Stock | D | 8,735 | 12,913 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | ROYSTON IVOR | BIOC | Restricted Stock Units | D | -8,735 | 0 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | ROYSTON IVOR | BIOC | Common Stock | D | 8,735 | 25,593 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | Wilson Margaret Faye | BIOC | Restricted Stock Units | D | -14,285 | 0 | ||||||
| 2015-07-08 | 2015-05-24 | 4 | Wilson Margaret Faye | BIOC | Common Stock | D | 14,285 | 23,359 | ||||||
| 2015-06-02 | 2015-06-01 | 4 | Singh Veena By spouse | BIOC | Common Stock | I | 3.1000 | 3,200 | 10 | 5,000 | ||||
| 2015-06-02 | 2015-05-29 | 4 | Singh Veena By spouse | BIOC | Common Stock | I | 3.0500 | 1,800 | 5 | 1,800 | ||||
| 2015-02-18 | 2015-02-13 | 4 | ROYSTON IVOR By Reporting Person's retirement account | BIOC | Warrant to Purchase Common Stock | I | 1.56 | 12,000 | 12,000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | ROYSTON IVOR By Reporting Person's retirement account | BIOC | Common Stock | I | 1.2500 | 12,000 | 15 | 16,858 | ||||
| 2015-02-18 | 2015-02-13 | 4 | HALE DAVID F By LLC | BIOC | Warrant to Purchase Common Stock | I | 1.56 | 40,000 | 40,000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | 1.2500 | 40,000 | 50 | 94,570 | ||||
| 2015-02-18 | 2015-02-13 | 4 | Neff Edward A. By corporation | BIOC | Warrant to Purchase Common Stock | I | 1.56 | 40,000 | 40,000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | Neff Edward A. By corporation | BIOC | Common Stock | I | 1.2500 | 40,000 | 50 | 187,386 | ||||
| 2015-02-18 | 2015-02-13 | 4 | Nall Michael W. | BIOC | Warrant to Purchase Common Stock | D | 1.56 | 12,000 | 12,000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | Nall Michael W. | BIOC | Common Stock | D | 1.2500 | 12,000 | 15 | 12,000 | ||||
| 2015-02-18 | 2015-02-13 | 4 | Chandler Marsha Alpert | BIOC | Warrant to Purchase Common Stock | D | 1.56 | 2,000 | 2,000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | Chandler Marsha Alpert | BIOC | Common Stock | D | 1.2500 | 2,000 | 2 | 7,078 | ||||
| 2015-02-18 | 2015-02-13 | 4 | Gerhardt Bruce | BIOC | Warrant to Purchase Common Stock | D | 1.56 | 20,000 | 20,000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 1.2500 | 20,000 | 25 | 25,250 | ||||
| 2015-02-18 | 2015-02-13 | 4 | HUEBNER BRUCE A | BIOC | Warrant to Purchase Common Stock | D | 1.56 | 12,000 | 12,000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | HUEBNER BRUCE A | BIOC | Common Stock | D | 1.2500 | 12,000 | 15 | 12,000 | ||||
| 2015-02-18 | 2015-02-13 | 4 | Wilson Margaret Faye | BIOC | Warrant to Purchase Common Stock | D | 1.56 | 4,000 | 4,000 | |||||
| 2015-02-18 | 2015-02-13 | 4 | Wilson Margaret Faye | BIOC | Common Stock | D | 1.2500 | 4,000 | 5 | 9,074 | ||||
| 2014-12-22 | 2014-12-18 | 4 | Singh Veena | BIOC | Stock option (right to buy) | D | 2.79 | 40,000 | 40,000 | |||||
| 2014-06-16 | 2014-06-12 | 4 | Nall Michael W. | BIOC | Stock Options (right to buy) | D | 5.35 | 75,000 | 75,000 | |||||
| 2014-06-06 | 3 | Trivedi Raaj | BIOC | No securities are beneficially owned | D | 0 | ||||||||
| 2014-06-06 | 2014-03-24 | 4 | Trivedi Raaj | BIOC | Stock Options (right to buy) | D | 7.50 | 43,000 | 43,000 | |||||
| 2014-05-20 | 2014-05-16 | 4 | Kachioff William G | BIOC | Stock Options (right to buy) | D | 4.38 | 50,000 | 50,000 | |||||
| 2014-05-20 | 2014-05-16 | 4 | ARNOLD LYLE J | BIOC | Stock Options (right to buy) | D | 4.38 | 35,000 | 35,000 | |||||
| 2014-05-20 | 2014-05-16 | 4 | Bischoff Farideh Z. | BIOC | Stock Options (right to buy) | D | 4.38 | 35,000 | 35,000 | |||||
| 2014-03-05 | 2014-02-10 | 4/A | Reiss Claire By trust | BIOC | Convertible Note (right to buy) | I | 10.00 | -163,399 | 0 | |||||
| 2014-03-05 | 2014-02-10 | 4/A | Reiss Claire By trusts | BIOC | Common Stock | I | 10.0000 | 420,430 | 4,204 | 1,843,743 | ||||
| 2014-02-24 | 2014-02-21 | 4 | HALE DAVID F | BIOC | Stock Options (right to buy) | D | 9.11 | 53,108 | 53,108 | |||||
| 2014-02-24 | 2014-02-21 | 4 | Kachioff William G | BIOC | Stock Options (right to buy) | D | 9.11 | 1,190 | 1,190 | |||||
| 2014-02-18 | 2014-02-13 | 4 | HALE DAVID F | BIOC | Stock Options (right to buy) | D | 8.88 | 70,000 | 70,000 | |||||
| 2014-02-18 | 2014-02-13 | 4 | ROYSTON IVOR | BIOC | Stock Options (right to buy) | D | 8.88 | 26,500 | 26,500 | |||||
| 2014-02-18 | 2014-02-13 | 4 | HUEBNER BRUCE A | BIOC | Stock Options (right to buy) | D | 8.88 | 22,000 | 22,000 | |||||
| 2014-02-18 | 2014-02-13 | 4 | Wilson Margaret Faye | BIOC | Stock Options (right to buy) | D | 8.88 | 51,000 | 51,000 | |||||
| 2014-02-18 | 2014-02-13 | 4 | Gerhardt Bruce | BIOC | Stock Options (right to buy) | D | 8.88 | 23,000 | 23,000 | |||||
| 2014-02-18 | 2014-02-13 | 4 | Chandler Marsha Alpert | BIOC | Stock Options (right to buy) | D | 8.88 | 23,000 | 23,000 | |||||
| 2014-02-18 | 2014-02-13 | 4 | Neff Edward A. | BIOC | Stock Options (right to buy) | D | 8.88 | 23,000 | 23,000 | |||||
| 2014-02-12 | 2014-02-10 | 4 | ROYSTON IVOR | BIOC | Warrants (right to buy) | D | 10.00 | 2,500 | 2,500 | |||||
| 2014-02-12 | 2014-02-10 | 4 | ROYSTON IVOR | BIOC | Restricted Stock Units (right to buy) | D | 9,285 | 9,285 | ||||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F By LLC | BIOC | Warrants (right to buy) | I | 10.00 | 36,302 | 36,302 | |||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F By LLC | BIOC | Warrants (right to buy) | I | 10.00 | 22,175 | 22,175 | |||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F | BIOC | Issuer?s repurchase right (obligation to sell) | D | 4.6200 | -10,204 | -47 | 0 | ||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F | BIOC | Restricted Stock Units (right to buy) | D | 53,662 | 53,662 | ||||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F | BIOC | Restricted Stock Units (right to buy) | D | 10,204 | 10,204 | ||||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F By LLC | BIOC | Convertible Notes (right to buy) | I | 10.00 | -47,181 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | HALE DAVID F By LLC | BIOC | Common Stock | I | 10.0000 | 47,181 | 472 | 54,570 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Wilson Margaret Faye | BIOC | Warrants (right to buy) | D | 10.00 | 1,250 | 1,250 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Wilson Margaret Faye | BIOC | Convertible Note (right to buy) | D | 10.00 | -2,650 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Wilson Margaret Faye | BIOC | Common Stock | D | 10.0000 | 2,650 | 26 | 5,074 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Gerhardt Bruce | BIOC | Warrants (right to buy) | D | 10.00 | 2,500 | 2,500 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Gerhardt Bruce | BIOC | Warrants (right to buy) | D | 10.00 | 500 | 500 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Gerhardt Bruce | BIOC | Convertible Note (right to buy) | D | 10.00 | -1,055 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Gerhardt Bruce | BIOC | Common Stock | D | 10.0000 | 1,055 | 11 | 5,250 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Chandler Marsha Alpert | BIOC | Warrants (right to buy) | D | 10.00 | 2,500 | 2,500 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Chandler Marsha Alpert | BIOC | Convertible Note (right to buy) | D | 10.00 | -5,078 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Chandler Marsha Alpert | BIOC | Common Stock | D | 10.0000 | 5,078 | 51 | 5,078 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Neff Edward A. | BIOC | Warrants (right to buy) | D | 10.00 | 28,801 | 28,801 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Neff Edward A. By corporation | BIOC | Warrants (right to buy) | I | 10.00 | 51,250 | 51,250 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Neff Edward A. By corporation | BIOC | Convertible Notes (right to buy) | I | 10.00 | -108,140 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Neff Edward A. By corporation | BIOC | Common Stock | I | 10.0000 | 108,140 | 1,081 | 147,386 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By trust | BIOC | Warrants (right to buy) | I | 10.00 | 58,802 | 58,802 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By corporation | BIOC | Warrants (right to buy) | I | 10.00 | 6,250 | 6,250 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By trusts | BIOC | Warrants (right to buy) | I | 10.00 | 119,000 | 119,000 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By corporation | BIOC | Convertible Notes (right to buy) | I | 10.00 | -13,453 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By trust | BIOC | Convertible Notes (right to buy) | I | 10.00 | -257,031 | 0 | |||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By corporation | BIOC | Common Stock | I | 10.0000 | 13,453 | 135 | 14,012 | ||||
| 2014-02-12 | 2014-02-10 | 4 | Reiss Claire By trusts | BIOC | Common Stock | I | 10.0000 | 257,031 | 2,570 | 1,680,344 | ||||
| 2014-02-04 | 3 | HALE DAVID F | BIOC | Common Stock | D | 10,204 | ||||||||
| 2014-02-04 | 3 | HALE DAVID F By LLC | BIOC | Common Stock | I | 7,389 | ||||||||
| 2014-02-04 | 3 | ROYSTON IVOR By Reporting Person?s retirement account | BIOC | Common Stock | I | 4,858 | ||||||||
| 2014-02-04 | 3 | Wilson Margaret Faye By Reporting Person?s retirement account | BIOC | Common Stock | I | 2,374 | ||||||||
| 2014-02-04 | 3 | Wilson Margaret Faye | BIOC | Common Stock | D | 2,424 | ||||||||
| 2014-02-04 | 3 | Wilson Margaret Faye By LLC | BIOC | Common Stock | I | 1,417 | ||||||||
| 2014-02-04 | 3 | Gerhardt Bruce | BIOC | Common Stock | D | 4,195 | ||||||||
| 2014-02-04 | 3 | Neff Edward A. By corporation | BIOC | Common Stock | I | 39,246 | ||||||||
| 2014-02-04 | 3 | Neff Edward A. | BIOC | Common Stock | D | 4,178 | ||||||||
| 2014-02-04 | 3 | Reiss Claire By corporation | BIOC | Common Stock | I | 559 | ||||||||
| 2014-02-04 | 3 | Reiss Claire By trusts | BIOC | Common Stock | I | 1,423,313 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
